BioCentury | Oct 4, 2010
Financial News

OpGen completes venture financing

...Type: Venture financing Raised: $17 million Investors: jVen Capital; CHL Medical Partners; Highland Capital Partners; Mason Wells...
BioCentury | Oct 4, 2010
Finance

Options for OpGen

...the new round with participation from other existing investors CHL Medical Partners; Highland Capital Partners; Mason Wells...
BioCentury | Sep 28, 2010
Financial News

Genomics company OpGen raises $17 million

...round led by existing investor jVen Capital. Existing investor CHL Medical Partners; Highland Capital Partners; Mason Wells...
BioCentury | Sep 17, 2007
Finance

Ebb & Flow

...Dan Broderick joined Prolog Ventures as a partner. Previously, he managed the biomedical fund at Mason Wells...
BioCentury | Sep 13, 2007
Financial News

OpGen raises $23.6 million

...co-led by new investors CHL Medical Partners; Highland Capital Partners; and Versant Ventures. Existing investor Mason Wells...
BioCentury | Dec 16, 2004
Company News

ZyStor, Symbiontics metabolic deal

...$8.5 million in the first tranche of a series B round of financing co-led by Mason Wells...
BioCentury | May 31, 2004
Emerging Company Profile

Corporate Profile

...Genome Institute; and Henry Ford Hospital Number of Employees: 7 Funds raised: $6 million Investors: Mason Wells...
BioCentury | Jul 31, 2000
Finance

To flip, or not to flip...

...VC fund that lists Biosite (BSTE), Inhale (INHL) and Tularik (TLRK) among its investments. Meanwhile, Mason Wells...
...has raised $30 million of a planned $75 million in a first closing of its Mason Wells...
BioCentury | Jul 25, 2000
Financial News

Venture fund closings

...De Novo Ventures and Mason Wells Biomedical Fund I each announced closings in their respective funds on...
...invest in companies involved in medical devices, genomics, biopharmaceuticals, drug delivery and internet health care. Mason Wells...
Items per page:
1 - 9 of 9
BioCentury | Oct 4, 2010
Financial News

OpGen completes venture financing

...Type: Venture financing Raised: $17 million Investors: jVen Capital; CHL Medical Partners; Highland Capital Partners; Mason Wells...
BioCentury | Oct 4, 2010
Finance

Options for OpGen

...the new round with participation from other existing investors CHL Medical Partners; Highland Capital Partners; Mason Wells...
BioCentury | Sep 28, 2010
Financial News

Genomics company OpGen raises $17 million

...round led by existing investor jVen Capital. Existing investor CHL Medical Partners; Highland Capital Partners; Mason Wells...
BioCentury | Sep 17, 2007
Finance

Ebb & Flow

...Dan Broderick joined Prolog Ventures as a partner. Previously, he managed the biomedical fund at Mason Wells...
BioCentury | Sep 13, 2007
Financial News

OpGen raises $23.6 million

...co-led by new investors CHL Medical Partners; Highland Capital Partners; and Versant Ventures. Existing investor Mason Wells...
BioCentury | Dec 16, 2004
Company News

ZyStor, Symbiontics metabolic deal

...$8.5 million in the first tranche of a series B round of financing co-led by Mason Wells...
BioCentury | May 31, 2004
Emerging Company Profile

Corporate Profile

...Genome Institute; and Henry Ford Hospital Number of Employees: 7 Funds raised: $6 million Investors: Mason Wells...
BioCentury | Jul 31, 2000
Finance

To flip, or not to flip...

...VC fund that lists Biosite (BSTE), Inhale (INHL) and Tularik (TLRK) among its investments. Meanwhile, Mason Wells...
...has raised $30 million of a planned $75 million in a first closing of its Mason Wells...
BioCentury | Jul 25, 2000
Financial News

Venture fund closings

...De Novo Ventures and Mason Wells Biomedical Fund I each announced closings in their respective funds on...
...invest in companies involved in medical devices, genomics, biopharmaceuticals, drug delivery and internet health care. Mason Wells...
Items per page:
1 - 9 of 9